The QualityStocks Daily Friday, June 14th, 2019

Today's Top 3 Investment Newsletters

AwesomeStocks (CLCI) +130.19%

QualityStocks (NXNN) +75.44%

Daily Trade Alert (BXG) +31.13%

The QualityStocks Daily Stock List

Upper Street Marketing, Inc. (UPPR)

NetworkNewsWire, OTC.Watch, OTC Markets, Financial Buzz, Street Insider, Emerging Growth, Investor Ideas, Wallet Investor, Proactive Investors, Dividend Investors, Stockwatch, News to Watch, Investors Hangout, and Stockopedia reported earlier on Upper Street Marketing, Inc. (UPPR), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Upper Street Marketing, Inc. is one of the only companies in the world to control every phase of the cannabidiol (CBD) extraction cycle from seed to consumer. The Company’s intention is to be a leader in FDA cGMP (Current Good Manufacturing Practice) capabilities in the hemp and CBD marketplace. It is established and entrenched in the Colorado hemp marketplace with significant opportunities for organic expansion and synergistic mergers and acquisitions. Upper Street Marketing’s wholly-owned subsidiary is Growing Springs Holdings Corporation.

Upper Street Marketing is under contract to cultivate 360 acres of hemp for 2019 and beyond. The Company owns a 100,000 square foot facility for processing Cannabidiol or CBD from hemp in Center, Colorado. Its plan is to be able to grow and process up to 1,000,000 pounds of bio-mass in 2019 and up to 4,000,000 pounds of bio-mass in 2020.

In addition, Growing Springs Holdings /Upper Street Marketing is negotiating an additional 3,000 acres of hemp for cultivation in Colorado for 2020 – 2023. The Company has leased a 13,000 square foot CBD approved laboratory facility in San Diego, California for the processing of CBD extracts. It will look to install capacity to produce 100,000 kilos annually of CBD Isolate over the next 36 months.

Upper Street Marketing (UPPR) and its subsidiary Growing Springs Holdings entered into an agreement to process 1.5 million pounds of hemp biomass into cannabidiol (CBD) isolates and distillates with a value of about $200 million. Fox Organic Farms will deliver the biomass from its 830-acre Saguache, Colorado cultivation to UPPR-affiliated extraction facilities in October, where it will undergo conversion into pharmaceutical-grade CBD products in exchange for a 50 percent share of the revenue.

Upper Street Marketing recently announced the closing of its recently announced acquisition of twenty percent of Catch Capital Partners, Inc. The Company issued five million shares to the Principals of Catch Capital Partners. Catch Capital Partners is a Canadian company advancing projects in the outdoor cannabis and hemp space.

Upper Street Marketing, Inc. (UPPR), closed Friday's trading session at $1.17, up 7.34%, on 64,786 volume with 105 trades. The average volume for the last 3 months is 44,912 and the stock's 52-week low/high is $0.05/$1.24.

chart

Theratechnologies, Inc. (THERF)

Zacks, TipRanks, Street Insider, StockScores, Real Investment Advice, The Stock Market Watch, Wallmine, Stockhouse, Stockwatch, Marketbeat, and Equity Clock reported previously on Theratechnologies, Inc. (THERF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A specialty pharmaceutical company, Theratechnologies, Inc. addresses unmet medical needs by bringing to market specialized therapies for people with orphan medical conditions, including those living with HIV. Founded in Montreal, Quebec in 1993, the Company has experienced Management and Board of Directors, with Financial, M&A, Pharmaceutical, Commercial, Regulatory, and Corporate governance expertise. Theratechnologies has its corporate office in Montreal.

The Company’s products and pipeline include Trogarzo® (MDR HIV-1); Trogarzo® IV slow push (MDR HIV-1); EGRIFTA® (HIV-associated lipodystrophy); and EGRIFTA® F4 (HIV-associated lipodystrophy). Its products and pipeline also include DoxKa (Ovarian Cancer), and DoceKa (Triple Negative Breast Cancer TNBC).

Focusing on HIV niche markets, Theratechnologies has two approved products. One is Trogarzo® (ibalizumab-uiyk) injection, which was approved by the Food and Drug Administration (FDA) on March 6, 2018. It is indicated for the treatment of patients with multidrug resistant HIV-1. It is first in a new class of antiretrovirals (CD4-directed post-attachment HIV-1 inhibitors). Commercial rights were acquired for the United States, Europe, and Canada from TaiMed Biologics. It has been commercially available since April 30, 2018 and commercialized by Theratechnologies.

The second approved product is EGRIFTA® (tesamorelin for injection). FDA approval was obtained in 2010. It is the only treatment approved for HIV-associated lipohypertrophy. It is also approved in Canada and Mexico and commercialized in the United States and Canada by Theratechnologies.

Today, Theratechnologies announced additional data from the recently completed study funded by the National Institutes of Health, led by Dr. Steve Grinspoon, and conducted at the Massachusetts General Hospital and Harvard Medical School and the National Institutes of Health. New data released by Theratechnologies demonstrate positive impact of Tesamorelin in patients with liver fibrosis.

New data from the study show a statistically significant difference in the progression of fibrosis for patients in the tesamorelin arm. In the tesamorelin group, only 10.5 percent of patients experienced progression of liver fibrosis versus 37.5 percent in patients receiving a placebo (p=0.04). Mr. Luc Tanguay, President and Chief Executive Officer of Theratechnologies, said, “Given the strong evidence coming from this study, we are now in a position to share our strategic approach for the development of tesamorelin for the potential treatment of NASH in people living with HIV. We look forward to sharing our development plan with investors and analysts, on Monday, June 17, 2019.”

Theratechnologies, Inc. (THERF), closed Friday's trading session at $5.60, up 7.25%, on 94,242 volume with 238 trades. The average volume for the last 3 months is 60,806 and the stock's 52-week low/high is $3.85/$10.61.

chart

CleanSpark, Inc. (CLSK)

Uptick Newswire, PR Newswire, Market Screener, Stockhouse, Insider Financial, Micro Cap Daily, Financial Buzz, MarketWatch, Marketbeat, Equities, GlobeNewswire, Pot Stock News, Insider Tracking, Wallet Investor, Stockwatch, Barchart, Trading View, Simply Wall St, YCharts, InvestorsHub, and Dividend Investor reported earlier on CleanSpark, Inc. (CLSK), and today we report on the Company, here at the QualityStocks Daily Newsletter.

CleanSpark, Inc. is a microgrid company with advanced engineering, software and controls for unique distributed energy resource (DER) and microgrid deployments. The Company provides advanced energy software and control technology that enables a plug-and-play enterprise solution to modern energy challenges. CleanSpark's customers include energy consumers and the distributed energy ecosystem at large: developers, installers, EPCs, IPPs, and energy storage vendors. The Company previously went by the name Stratean, Inc. It changed its name to CleanSpark, Inc. in November 2016. CleanSpark has its corporate office in Utah.

CleanSpark’s services consist of intelligent energy monitoring and controls, microgrid design and engineering, microgrid consulting services, and turn-key microgrid implementation services. The Company's software enables energy users to obtain resiliency and economic optimization. Its software is uniquely capable of enabling a microgrid to be scaled to the user's specific needs. It can be broadly implemented across commercial, industrial, military, agricultural and municipal deployment.

CleanSpark’s Microgrid Value Stream Optimizer outputs are a client’s customized guide to maximizing their energy project’s ROI (Return on Investment). State-of-the-art data analytics account for real costs, precise utility rate models, equipment performance, and actual energy consumption. They outline what type of energy resources are to be built, what it will cost, and how it will perform upon deployment.

CleanSpark’s mPulse software is an innovation in controls capable of integrating manifold Distributed Energy Resources (DER). This includes storage, renewables and fossil fuel technologies. The Company’s intelligent software package collects, archives and analyzes data 24/7 providing real-time control and reporting. Pertaining to Engineering & Grid Development Services, CleanSpark’s mVSO provides critical information. It is also the starting point for CleanSpark’s microgrid development services.

Last week, CleanSpark announced record equipment sales and shipments for the month of May. Equipment sales for May were greater than $1 million, versus equipment sales of $431,000 during the first three months of 2019.

In total, equipment sales for the quarter ending June 30, 2019 are projected to surpass $1.5 million. Equipment Sales for the Company’s fiscal year are on course to surpass previous estimates of $4 million. CleanSpark's contracted back log for equipment also increased to $6.1 million. This represents an increase of more than $2 million since March 31, 2019.

CleanSpark, Inc. (CLSK), closed Friday's trading session at $2.00, up 11.11%, on 178,862 volume with 182 trades. The average volume for the last 3 months is 116,618 and the stock's 52-week low/high is $1.10/$15.01.

chart

Emerald Health Therapeutics, Inc. (EMHTF)

Micro Cap Daily, Investing Haven, Midas Letter, Technical420, New Cannabis Ventures, Stockwatch, MarketWatch, Daily Marijuana Observer, NIC Investors, Proactive Investors, Small Cap Power, Stock of the Week, Green Leaf Pot Stocks, Pot Stock News, Micro Small Cap, Midas Letter, Trading View, Wallet Investor, GuruFocus, Insider Financial, Stockhouse, and Barchart reported earlier on Emerald Health Therapeutics, Inc. (EMHTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis in Canada. It is a Health Canada Licensed Producer (LP) of medical cannabis with decades of experience in pharmaceutical innovation. The Company was formerly known as T-Bird Pharma, Inc. It changed its corporate name to Emerald Health Therapeutics, Inc. in June 2015. The Company has its head office in Victoria, British Columbia.

Emerald Therapeutics is part of the Emerald Health group. The Emerald Health group is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits through interacting with the human body’s endocannabinoid system.

Emerald Health Therapeutics’ focus is on enhancing health through cannabis science. It produces and sells dried cannabis and cannabis oil for medical and recreational purposes. Emerald is a vertically integrated, seed-to-sale company. It has combined core competencies from decades of experience in pharmaceutical innovation with large-scale agriculture expertise centered on developing value-added cannabis-based products with potential wellness and medical benefits.

Emerald is leveraging industry-leading life sciences, cannabis and greenhouse growing expertise to achieve highly competitive low cost, value-added cannabis products. It entered into a strategic alliance with Factors R&D Technology, Inc., a division of Factors Group of Nutritional Companies, Inc., Canada’s largest nutritional supplement marketer and manufacturer. This exclusive arrangement provides access to an industrial-scale production facility, capable of processing up to 1M kg of biomass per annum and softgel production capacity of up to 600M capsules per annum.

Emerald Health Therapeutics has secured cannabis supply agreements with the Provinces of British Columbia, Alberta, Saskatchewan, Ontario, Québec, Newfoundland and Labrador, and the Yukon Territory. The Company is advancing prospective supply agreements with all remaining provinces and territories to develop a significant presence in the recreational market.

Emerald’s 50 percent-owned Pure Sunfarms JV in British Columbia is licensed to cultivate in 1.03 million square feet of the first of its two 1.1 million square foot greenhouses. The capacity of each greenhouse is estimated to exceed 75,000 kg of cannabis annually. Emerald’s Verdélite operation in Québec is completing the build out of its 88,000 square foot indoor cultivation facility and is scaling up production.

This week, Emerald Health Therapeutics reported that it expanded its agreement to purchase harvested hemp flower and leaf, or hemp chaff, from Emerald Health Hemp, Inc. (EHH) from 1,000 to 1,200 acres for 2019. EHH is a wholly-owned subsidiary of Emerald Health Sciences. and a related party of Emerald.

Based on last year’s harvest, Emerald expects production from the 1,200 acres to be at least 270,000 kg of hemp chaff in 2019 with, conservatively, roughly 2 percent cannabidiol (CBD) content. Emerald estimates that this hemp may yield 3,500 kg of extracted CBD that it plans to use to manufacture premium oils, softgels and associated value-added products for Canadian adult-use and medical consumers.

Emerald Health Therapeutics will participate in the Oppenheimer 19th Annual Consumer Growth and E-Commerce Conference on June 18, 2019 in Boston, Massachusetts. Mr. Bernie Hertel, Vice President of Finance and Communications, Emerald Health Sciences, will present a corporate overview and be available for 1x1 meetings. Presentation Date and Time, is Tuesday, June 18, 2019, 9:20 AM – 9:55 AM EDT at the Four Seasons Hotel in Boston.

Emerald Health Therapeutics, Inc. (EMHTF), closed Friday's trading session at $2.14, down 5.31%, on 272,371 volume with 472 trades. The average volume for the last 3 months is 345,817 and the stock's 52-week low/high is $1.48/$4.50.

chart

New Pacific Metals Corp. (NUPMF)

Junior Mining Network, The Prospector News, Wallet Investor, Stockwatch, Stockhouse, Streetwise Reports, Northern Miner, Investorx, and MineStat reported earlier on New Pacific Metals Corp. (NUPMF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

New Pacific Metals Corp. is exploring and developing precious and base metals properties in South America, Canada and China. Its flagship property is the Silver Sand project in the Potosí Department of Bolivia. The Company previously went by the name New Pacific Holdings Corp. It changed its name to New Pacific Metals Corp. in July of 2017. New Pacific Metals is headquartered in Vancouver, British Columbia.

The Company’s largest shareholders are Silvercorp Metals, Inc. (TSX:SVM) and Pan American Silver Corp. (TSX: PAAS). New Pacific Metals acquired Alcira, the owner of the Silver Sands project in July 2017. Alcira has seven silver-polymetallic mineral properties or ATEs (Temporary Special Authorization) in Bolivia.

The most significant property is the Silver Sand Property, which has had some small-scale, historic mining. It was drilled during the period 2012 through 2015 by Alcira. The other six are early-stage exploration projects that have either been subject to limited small-scale mining or historical drilling.

New Pacific Metals acquired the Tagish Lake Gold Project in 2010 via the 100 percent acquisition of Tagish Lake Gold Corp., which is continuing as a wholly-owned subsidiary of New Pacific. The Tagish Lake Gold Project comprises 1,512 mineral claims encompassing roughly 254 square kilometers.

New Pacific Metals acquired the RZY early stage silver-lead-zinc project in April of 2013. It is located in Qinghai Province, China. New Pacific owns 100 percent of Fortress Mining, Inc. (FMI), a private company. The Project is FMI’s chief asset.

Recently, New Pacific Metals announced its unaudited condensed consolidated interim financial results for the three and nine months ended March 31, 2019. Net loss attributable to equity holders of the Company for the three months ended March 31, 2019 was $359 or $0.00 per share (three months ended March 31, 2018 - net loss of $258,719 or $0.00 per share).

New Pacific’s financial results were primarily impacted by income from investments of $1,552,446 versus a loss of $35,551 in the prior year quarter; operating expenses of $1,128,183 versus $748,893 in the prior year quarter; and foreign exchange loss of $431,492 versus a gain of $474,432 in the prior year quarter. For the nine months ended March 31, 2019, net loss attributable to equity holders of New Pacific Metals was $279,104 or $0.00 per share versus a net loss of $2,906,517 or $0.02 per share for the nine months ended March 31, 2018.

New Pacific Metals Corp. (NUPMF), closed Friday's trading session at $1.58, up 8.22%, on 1,300 volume with 3 trades. The average volume for the last 3 months is 8,509 and the stock's 52-week low/high is $0.8564/$1.89.

chart

Taptica International Ltd. (TTTPF)

Market Wire News, Street Insider, Stockhouse, and Wallet Investor reported earlier on Taptica International Ltd. (TTTPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Taptica International Ltd. is a global end-to-end mobile advertising platform. It helps the world’s leading brands reach their most valuable users with the broadest range of traffic sources available today. The Company, together with its subsidiaries, provides performance-based mobile marketing and brand advertising services. Taptica has operations in greater than 60 countries. The Company was previously known as Marimedia Ltd. It changed its name to Taptica International Ltd. in September of 2015. Taptica International is based in Tel Aviv, Israel.

In essence, Taptica International offers data-focused marketing solutions. These solutions drive execution and powerful brand insight in mobile, leveraging video, native, as well as display to reach the most valuable users for every application (app), service, and brand.

The Company powers data-driven solutions for stronger targeting and mobile campaign analyses. This is so it can deliver the right ads to the right users, at just the right moments. Taptica delivers relevant audiences at scale with precision targeting capabilities and reengagement tools across mobile and social channels.

Taptica International’s proprietary technology stack leverages dynamic supply segmentation, quality assurance algorithms, and a premier optimization engine. The Company’s optimization engine intelligently considers audiences, forecasting those that yield the best performance goals. Taptica's exclusive engine matches the most relevant supply channels with its unique demands.

The Company’s mobile publisher solution offers high-quality direct and brand-safe traffic sources at worldwide scale. With competitive rates and custom promotional roadmaps by traffic specifications, user base, and individual needs, Taptica International works to provide the highest potential revenue streams across digital screens.

Regarding Social, Taptica provides world-class technology, together with big data and professional experience, to secure maximum ROI (Return on Investment) on every social channel. Concerning Video, the Company’s acquisition of Tremor Video’s demand side platform creates a strong market force between their two technologies and teams.

Taptica International works with more than 450 advertisers including Amazon, Disney, Twitter, OpenTable, Expedia, and Zynga. The Company works with more than 50,000 supply and publishing partners around the world.

                   

Taptica International Ltd. (TTTPF), closed Friday's trading session at $1.49, up 7.97%, on 35,000 volume with 2 trades. The average volume for the last 3 months is 4,749 and the stock's 52-week low/high is $1.32/$4.22.

chart

US Nuclear Corp. (UCLE)

NetworkNewsWire, Stockwatch, Research Pool, Uptick Newswire, Emerging Growth, Stock News Now, Real Investment Advice, Stockhouse, Equities, Insider Financial, Dividend Investor, Wallet Investor, Simply Wall St, Investing, and GlobeNewswire reported earlier on US Nuclear Corp. (UCLE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

US Nuclear Corp. is a world leading manufacturer of advanced radiation and chemical detection and UAV instrumentation. The Company has three operating divisions: Optron Scientific Company, Inc. d/b/a Technical Associates (TA), Overhoff Technology (OTC), and Electronic Control Concepts (ECC). Through these, US Nuclear harbors greater than 100 years of combined experience in supplying top of the line instrumentation to any industry utilizing radionuclides. US Nuclear is headquartered in Canoga Park, California.

The Company’s newest product development is the incorporation of radiation and chemical sensors with drone mounted platforms. Serving an array of industries, this partnership of technology is creating a pioneering new industry - Aerial Radiation and Chemical Detection. The Company’s strategic partnership with FlyCFam UAV provides a complete package to the customer that flies in all-weather, heavy winds, and with a heavy payload. This provides the opportunity to fly numerous sensors at one time with real-time wireless download.

US Nuclear designs, manufactures and markets a branded, complete line of radiation and chemical detection instrumentation. These include specialties such as drone based aerial radiation detection, advanced Tritium and Carbon-14 monitoring technology, and real-time continuous water monitoring. The Company provides measurement instrumentation for the nuclear energy industry and for emerging technological processes, including Fusion, Thorium and Molten Salt (MSR) reactor technologies domestically and internationally.

The Technical Associates (TA) division excels in product engineering for radiation measurement and safety instruments for a varied range of nuclear industry requirements. TA places special emphasis on air and water monitoring. This includes, but is not limited to, drinking water, sea water, and wastewater monitors; i.e. developing the world’s only real-time continuous Alpha, Beta, Gamma, and Tritium in water monitor capable of measuring at or below EPA/PAG level guidelines.

US Nuclear and Magneto-Inertial Fusion Technologies, Inc. (MIFTI) signed an agreement that grants US Nuclear 500,000 shares of MIFTI stock, the option to acquire up to 10 percent of MIFTI, and non-exclusive global rights to manufacture and sell MIFTI’s patented thermonuclear fusion power generator. MIFTI’s fusion power generator can produce clean, base load electric power for the U.S. and other power grids and wherever small modular electric power sources are needed. MIFTI is a Department of Energy Advanced Research Projects Agency – Energy (DOE/ARPA-E) awardee and benefits from support by the National Nuclear Security Administration (NNSA).

US Nuclear Corp. (UCLE), closed Friday's trading session at $1.18, up 25.53%, on 80,728 volume with 76 trades. The average volume for the last 3 months is 55,952 and the stock's 52-week low/high is $0.202/$2.85.

chart

School Specialty, Inc. (SCOO)

NetworkNewsWire, Zacks, Simply Wall St, MarketWatch, Wallmine, Stockopedia, Wallet Investor, Seeking Alpha, Marketbeat, YCharts, Stockhouse, Capital Cube and 4-Traders reported earlier on School Specialty, Inc. (SCOO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

School Specialty, Inc. is a foremost provider of unique products and solutions that support integrated learning environments for improved student social, emotional, mental and physical well-being. The Company designs, develops and delivers the widest array of innovative and proprietary products, programs and services to the education marketplace. This includes essential classroom supplies, furniture, educational technology, supplemental learning resources, science-based curriculum, and evidence-based safety training & security. Founded in 1959 and OTCQB-listed, School Specialty is headquartered in Greenville, Wisconsin.

The Company empowers leaders with modern educational ecosystems that optimize student outcomes. School Specialty creates holistic environments, from crayons to curriculum, furniture to technology. Its products work together to create spaces where students can grow mentally, physically, socially and emotionally.

School Specialty offers its own proprietary products from best-in-class brands like Sax, SSI Guardian, Frey, Foss and School Smart. It also offers some of the most trusted third-party brands in the educational market. The Company has grown into an enterprise that includes more than 70 subject matter experts and other industry thought leaders always seeking out and sharing leading edge ideas to advance modern education. School Specialty mainly serves the preK-12th grade market. Nonetheless, it has recently expanded its presence in non-traditional channels, including e-commerce and retail. The Company offers its products via two operating groups: Distribution and Curriculum.

This past February, School Specialty announced that its Board of Directors appointed Mr. Michael Buenzow as interim Chief Executive Officer (CEO). Mr. Buenzow succeeds Mr. Joseph Yorio, President and CEO of School Specialty since 2014, who resigned from the Company to pursue other opportunities. Mr. Buenzow began his role effective immediately.

Mr. Buenzow is a proven executive. He has over 25 years of interim management and operational experience, having served as interim CEO for manifold companies including Bush Furniture and Huffy Bicycle. Mr. Buenzow’s experience covers several industries. These include furniture, retail and consumer products. Based in Chicago, Mr. Buenzow presently is a Senior Managing Director at FTI Consulting.

Recently, School Specialty provided results for its fiscal Q4 and fiscal year ended December 29, 2018 and its initial outlook for fiscal 2019. Revenue was $673.5 million for the fiscal year ended December 29, 2018, versus $658.4 million in fiscal 2017. This represents an increase of 2.3 percent.

Fiscal Q4 2018 Revenue of $114.6 million was up 1.9 percent versus the previous year period. However, it was roughly 5.4 percent below expectations because of declines in the Science Curriculum category and lower than expected Revenue growth in the Supplies, Furniture and Instruction & Intervention categories.

School Specialty provided the following financial outlook for fiscal 2019: Total Revenue of roughly $705 to $720 million. This represents a 5-7 percent increase year-over-year. The expectation is that Revenue growth will be driven by growth in the Science Curriculum, Furniture, and Supplies categories. The Company expects stable performance in Instruction & Intervention as the integrated sales organization matures and new products are launched. The expectation is that growth in these areas will be partially offset by declines in Agendas and A/V Tech.

School Specialty, Inc. (SCOO), closed Friday's trading session at $5.45, up 0.93%, on 6,020 volume with 15 trades. The average volume for the last 3 months is 4,848 and the stock's 52-week low/high is $5.35/$20.02.

chart

Technicolor SA (TCLRY)

Amigo Bulls, MarketWatch, The Street, Wallmine, Capital Cube, 4-Traders, Wallet Investor, Zacks, Seeking Alpha, GuruFocus, Market Screener, Marketbeat, Financial Content, Barchart, Morningstar, otc.watch, Last10k, Stockhouse, Trading View, Dividend Investor, and YCharts reported earlier on Technicolor SA (TCLRY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Technicolor SA provides diverse communication and video technologies, finished products, systems, equipment, and services for businesses and professionals in the entertainment and media industries globally. Its award-winning artists and technologists work with the creative community across film, television, gaming, and advertising to bring the universal art of storytelling to audiences globally. The Company is based in Issy-les-Moulineaux, France. Technicolor lists on the OTC Markets Group’s OTCQX.

The Company engineers next-generation home network and video solutions. These solutions allow bandwidth intensive content to be distributed at gigabit speeds and enjoyed seamlessly irrespective of place, device or time.

Technicolor operates via two segments - Entertainment Services and Connected Home. The Entertainment Services segment provides production services; visual effects and animation services for feature films, TV series, advertising, and video games; computer generated imagery animation services; on-set, color correction, VFX integration, and sound services. It also replicates, packages, and distributes video, game and music DVD, Blu-ray, and CD discs. Moreover, it offers turnkey integrated supply-chain solutions.

The Connected Home segment designs and supplies set-top boxes, broadband modems and gateways, and Internet of Things (IoT) connected devices. It also designs and supplies multi-device communication software, smart home applications, and related professional services.

In February, Technicolor announced it received a binding offer and entered into exclusive negotiations with InterDigital (IDCC) for the sale of its Research & Innovation activity. Of note is that InterDigital acquired Technicolor’s Patent Licensing business last year. InterDigital is a mobile technology research and development company.

Mr. Frederic Rose, Technicolor’s Chief Executive Officer, stated: "This proposed transaction continues the simplification of the Group’s structure while ensuring that its R&I teams join a world class technological organization. As a result, Technicolor will henceforth be able to focus its resources solely on its operating businesses."

Technicolor previously announced its results for the full year 2018. Revenues from Continuing Activities were €3,988 million, down 3 percent year-on-year at constant rate, with an Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of €266 million versus €341 million in 2017. Sales in the second half of the year increased by 3 percent at constant rate, boosted in particular by a strong 5 percent during the last quarter.

Recently, Technicolor increased its investments in organic growth in Production Services and in the transformation program in Connected Home. The expectation is that these initiatives will continue over the next few years in well-defined areas.

Technicolor SA (TCLRY), closed Friday's trading session at $0.979, up 5.27%, on 2,000 volume with 1 trade. The average volume for the last 3 months is 615 and the stock's 52-week low/high is $0.93/$1.74.

chart

Nutriband, Inc. (NTRB)

Market News Updates, Penny Stock Hub, Morningstar, Insider Monkey, Simply Wall St, GuruFocus, Barchart, InsiderMole, 4-Traders, The Street, Stockopedia, OTC Markets, MarketWatch, InvestorsHub, Stockhouse, last10k, Market Screener, and Stockwatch reported previously on Nutriband, Inc. (NTRB), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Nutriband, Inc. is a health and pharmaceutical Company listed on the OTC Markets Group’s OTCQB. The basis of all its products is around the science of Transdermal /Topical technologies. Nutriband Life Sciences is the pharmaceutical division of Nutriband, Inc. A Nevada corporation, Nutriband has its corporate office in Orlando, Florida.

The design of Nutriband’s products is on the principle that molecular combinations can be absorbed not only orally but also via the skin. Because of the intake method, all of the Company’s products contain nothing but the bare essential ingredients. This is because there is no need for binders, fillers or unwanted animal by-products such as gelatine.

The Nutriband Life Sciences division concentrates on the development, research and marketing of unique drug delivery systems. At present, its drug pipeline is in formulation, feasibility, and pre-clinical evaluation.

Last year, Nutriband acquired 4P Therapeutics, Inc. 4P Therapeutics becomes the Pharmaceutical and Development arm of Nutriband. 4P Therapeutics has a specific emphasis on Transdermal and Topical Technologies, prescription drugs, as well as clinical development.

Included in the acquisition of 4P Therapeutics’ Intellectual Property (IP) Portfolio is Defent™ abuse deterrent patch technology. This is an opioid abuse deterrent platform. It is for the transdermal delivery of opioid-based medications. Defent™ reduces the risk of abuse and misuse, creating a safer treatment for patients.

In September of 2018, Nutriband signed the definitive acquisition agreement to acquire Carmel Biosciences, Inc. According to this deal, Nutriband acquires the NDA and ownership rights to Food and Drug Administration (FDA) approved Prexxartan™, the ownership and rights to develop and market Carmel's pipeline including CAR-509, CAR-510, CAR-511 and CAR-512 now in Pre IND phase, and rights to Carmel's clinically tested nutraceutical line.

Recently, Nutriband announced that the United States Patent and Trademark Office (USPTO) granted the Company's request for Prioritized Examination (Track One) of the U.S. patent application for "Abuse and Misuse Deterrent Transdermal System" submitted by its subsidiary, 4P Therapeutics LLC.

Track One gives Nutriband's application special status with fewer requirements than the present accelerated examination program and without having to perform a pre-examination search. Nonetheless, the application still needs to be reviewed by the USPTO. Moreover, the grant of Track One status does not mean that a patent will be granted.

Nutriband, Inc. (NTRB), closed Friday's trading session at $7.55, up 0.80%, on 398 volume with 4 trades. The average volume for the last 3 months is 731 and the stock's 52-week low/high is $4.01/$12.70.

chart

Processa Pharmaceuticals, Inc. (PCSA)

NetworkNewsWire, Infront Analytics, Financial Content, Stockhouse, Barchart, Dividend Investor, Stockflare, MarketWatch, Biz Journals, Marketbeat, TradingView, PR Newswire, Stockopedia, Morningstar, YCharts, InvestorsHub, Simply Wall St, last10k, Biospace, and 4-Traders reported previously on Processa Pharmaceuticals, Inc. (PCSA), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter. 

Processa Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company based in Hanover, Maryland. It is developing products to improve the survival and/or quality of life for patients who have high unmet medical need conditions. In October of 2017, the Company acquired the assets of Promet Therapeutics, LLC. It assembled a proven regulatory science development team, management team, as well as Board of Directors. Processa Pharmaceuticals lists on the OTC Markets Group’s OTCQB.

The Processa Pharmaceuticals Team are experts in developing drug products from IND enabling studies to NDA submission. The Company’s plan is to have a pipeline of drugs that already have some proof-of-concept clinical data supporting its clinical use in the indication selected and in 2-4 years following acquisition will either have completed the pivotal study or be ready for a pivotal study and out-licensing.

Processa’s lead product is PCS-499. It will be investigated for the treatment of Necrobiosis Lipoidica, a necrotizing skin condition, caused by several pathophysiological changes. PCS-499 represents the first Processa Pharmaceuticals drug that can potentially be used in a number of unmet medical need conditions.

A second unmet medical need under investigation is the use of PCS-499 to treat radiation-related adverse effects in head & neck cancer. For both indications there is no Food and Drug Administration (FDA) approved treatments. In addition, the present standard of care is not adequate for patients.

Processa Pharmaceuticals announced in 2018 that the FDA granted the Company clearance to proceed with a Phase 2 clinical trial of PCS-499 in patients with Necrobiosis Lipoidica (NL) under an earlier submitted Investigational New Drug (IND) application. NL is a chronic, disfiguring condition affecting the skin and the tissue under the skin typically on the lower extremities with no currently approved FDA treatments. PCS-499 may provide a solution since PCS-499 and its metabolites affect numerous biological pathways, several of which contribute to the pathophysiology associated with NL.

Recently, Processa Pharmaceuticals announced that the American Academy of Dermatology (AAD) selected the Processa presentation on the “Study Design and Preliminary Safety and Tolerability of PCS499 for Treatment of Necrobiosis Lipoidica (NL)” for an oral presentation and ePoster at the 2019 Annual Meeting of Washington, DC, March 1-5, 2019. Dr. Maya Das, VP of Clinical Research at Processa Pharmaceuticals will deliver the presentation.

Processa Pharmaceuticals also recently announced the dosing of the first patient in the Phase 2 Necrobiosis Lipoidica (NL) clinical trial for PCS-499, taking place at 2 sites - University of Pennsylvania and University of Pittsburgh Medical Center (UPMC). The principal goal of the trial is to evaluate the safety and tolerability of PCS-499 in patients with NL. Nonetheless, the expectation is that the safety and efficacy data collected from the study will provide information for the design of future larger clinical trials.

Processa Pharmaceuticals, Inc. (PCSA), closed Friday's trading session at $2.40, up 3.23%, on 521 volume with 4 trades. The average volume for the last 3 months is 251 and the stock's 52-week low/high is $1.50/$4.78.

chart

Nexeon MedSystems, Inc. (NXNN)

NetworkNewsWire, Taglich Brothers, YCharts, Stockwatch, Wallet Investor, Street Insider, Penny Stock Hub, Awesome Penny Stocks, TipRanks, Stockhouse, Stockopedia, Zacks, Barchart, and InvestorsHub reported previously on Nexeon MedSystems, Inc. (NXNN), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Nexeon MedSystems, Inc. centers on providing innovative neurostimulation products. Its focus is on providing neurostimulation products that improve the quality-of-life of patients suffering from debilitating neurological diseases. Nexeon MedSystems has offices in Dallas, Texas and Liege, Belgium (Nexeon MedSystems Belgium SPRL). The Company’s shares trade on the OTC Markets Group’s OTCQB.

Nexeon MedSystems Belgium, SPRL (NMB) has acquired Medi-Line. This is a Belgian medical device manufacturer. Currently, Medi-Line serves numerous medical device customers in 16 nations. It has multi-year contracts with Fortune 500 companies.

MedSystems is an international bioelectronics medical device company. It has developed and commercialized a neurostimulation system. The system can be used to treat a variety of neurological diseases. Neurostimulation systems are used to restore neuronal function. The Company’s SYNAPSE™ device is the platform used in a process called Deep Brain Stimulation (DBS).

The platform acts like a brain pacemaker sending electrical pulses to specifically targeted areas in the brain. SYNAPSE™ reduces shortcomings in present-day DBS therapy. It enables the detection, measurement, as well as collection of brain signals, while simultaneously providing targeted DBS therapy. Furthermore, it provides directional stimulation that limits side effects.

Additionally, manifold stimulation frequencies permit increased therapy range. As well, rechargeable means a greater range of available therapies and rechargeable enables one surgery in comparison to many.

Recently, Nexeon MedSystems announced that it received grant matching funds from the Puerto Rico Science, Technology, and Research Trust. The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) earlier awarded a $830,000 grant to Nexeon’s wholly-owned subsidiary, Nexeon MedSystems Puerto Rico Operations Corporation (NMPROC, Nexeon PR).

This funding will go to support the development of novel cloud-based software to improve programming for deep brain stimulation. The National Institutes of Health announced funding of over 200 new awards, totaling greater than $220 million, by way of the Brain Research Advancing Innovative Neurotechnologies (BRAIN) Initiative.

Nexeon MedSystems, Inc. (NXNN), closed Friday's trading session at $3.00, up 75.44%, on 1,128 volume with 8 trades. The average volume for the last 3 months is 100 and the stock's 52-week low/high is $1.100/$9.50.

chart

Sunset Island Group, Inc. (SIGO)

MicrocapVoice, PennyStockSpy,  OTCPicks,  and 007 Stock Chat reported earlier on Sunset Island Group, Inc. (SIGO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

 OTCQB-listed, Sunset Island Group, Inc. provides consulting and advisory services to clients operating in the medical marijuana business space.  The Company concentrates on providing a licensed manufacturing facility to clients for producing products, including oils and edibles. Sunset Island Group has its corporate office in San Clemente,  California. 

The Company’s vision is to establish a fully integrated business, which provides turnkey solutions to the medical cannabis industry. Its primary emphasis is on providing a licensed facility where companies can manufacture and produce their products. In addition, Sunset Island will provide distribution for companies via an established network of dispensaries. 

Sunset Island Group earlier secured a lease on a property approved for cannabis cultivation. The Company for permits for 22,000 square feet of green house space. The expectation is that the 22,000 square feet of green house space will be able to produce up to 4,000 pounds of medical cannabis each year.  

Sunset Island announced last year that it initiated development of a CBD dietary supplement product. The initial product will feature a 2-oz stress relief beverage made from highest quality legal Hemp/CBD oil and real fruit. 
 
Sunset Island will continue to develop products that will address the demands in the worldwide dietary supplements market. This market is targeted to soon reach greater than $200 billion.  The product will undergo development by a trained French Chef with more than two decades of experience in Product Development and Food Production.
 
Sunset Island Group is performing a retrofit to its current grow space that will considerably increase the amount of cannabis product produced with each harvest. Furthermore, the Company announced in November 2017 that it commenced an aggressive expansion of its cannabis product line.

The Company’s retro fit is two phases. Phase 1 is the retro fit of the present greenhouse operations. Phase 2 is the constructing of a new greenhouse on its bare land or retrofitting another greenhouse on the property.

The aim of the retro fit for Phase 1 is to increase the growable space in the current greenhouse to about 22,000 (with a vertical grow) with roughly 85 percent being canopy space (or around 19,000 square feet). The Company's objective is to yield 0.08-0.10 pounds per growable space and to have five harvests.

Sunset Island Group has received its temporary licenses from the State of California for Distribution, Cultivation and Manufacturing. The licenses are for Adult Use (Recreational) and Medicinal. The licenses permit Sunset Island to sell and transport its own product to dispensaries across California.

The manufacturing license allows it to start manufacturing products such as vape cartridges, edibles, as well as extracts. At present, Sunset Island is in the process of converting one of its cold storage rooms into a clean room to commence manufacturing these products.

Sunset Island Group, Inc. (SIGO), closed Friday's trading session at $0.19, up 50.21%, on 3,310 volume with 3 trades. The average volume for the last 3 months is 8,176 and the stock's 52-week low/high is $0.108/$0.75.

chart

TransAKT Ltd. (TAKD)

OTC Markets, Stockhouse, Barchart, and The Street reported on TransAKT Ltd. (TAKD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

TransAKT Ltd. is a manufacturer of highly unique agricultural equipment used to grow a broad array of vegetables and fruit employing simulated sunlight from LED lamps in an indoor proprietary hydroponic system. In addition, the Company is an international distributor of LED lighting products centered on serving the fastest developing market of commercial, hospitality, and outdoor lighting. OTCQB-listed, TransAKT is based in Hong Kong.

The Company’s commitment is to helping business owners protect the environment through superior energy efficiency - replacing current non-energy-efficient light sources with energy-efficient light sources. Additionally, TransAKT is focusing on eliminating the use of chemical fertilizers and pesticides utilizing the latest hydroponic agricultural technology and pure nutrients.

The nutrient solutions used in production with its hydroponic systems leave no heavy metal and chemical residues. TransAKT’s product line includes commercial production and home growing systems.

TransAKT’s wholly-owned subsidiary is Vegfab Agriculture Technology Co., Ltd. Vegfab was created in 2010 by a team of ecologically minded semiconductor specialists knowledgeable about LED materials.

Furthermore, TransAKT is looking for opportunities to develop a BIO-technology business in China. The Company says that the cordyceps business is one project with the greatest potential. It has engaged a team of approximately 10 experts in BIO technology engineering to develop an extended product mix. These products will debut in China in the next few years.

Vegfab’s product line includes systems for commercial production and a home growing system, which enables families to grow safe and clean fruit and vegetables in their homes. Vegfab products are the subject of numerous patents. These include ones for vertically wall-mounted LED lights, and ventilation systems for grow boxes.

Vegfab provides complete growing systems consisting of proprietary simulated sunlight LED boards; growing racks in diverse configurations for commercial and residential applications; environment control and plant nutrition control components; portable work tables and ladders; fruit and vegetable seeds and nutrition products; and vegetables.

Vegfab’s vegetable production factory in Yangmei City, Taiwan is the only mass production facility for vegetables in Taiwan. The facility utilizes innovative technology to produce exceptional yields from a very small space. Production is very efficient through the use of simulated sunlight from LED lamps, up to 85 percent automated.

TransAKT Ltd. (TAKD), closed Friday's trading session at $0.15115, even for the day. The average volume for the last 3 months is 175 and the stock's 52-week low/high is $0.015/$0.16.

chart

The QualityStocks Company Corner

Hemptown USA

The QualityStocks Daily Newsletter would like to spotlight Hemptown USA.

Hemptown USA, a privately held company headquartered in Southern Oregon’s Emerald Triangle, is poised in a market where cannabigerol (“CBG”) could rival cannabidiol (“CBG”) in years to come, potentially becoming the market’s next big thing. A recent article discussing this reads, “Through Hemptown USA’s ‘soil to oil to shelf’ methodology, the company will be producing broad-spectrum CBD and CBG crudes, distillates, pure isolates, multiple cannabinoid formulations and branded products. This year’s CBG focus positions Hemptown as a leading CBG producer in the United States in 2019 and beyond. In addition to the Oregon farm, the company is also growing in Kentucky and Colorado. Its present footprint comes in at just over 1,500 acres, but plans are in place to scale up operations by 2020 — expanding cultivation to 2,500 acres and increasing potential revenues up to $200 million.” To view the full article, visit http://ibn.fm/9Drw6.

Hemptown USA, headquartered in Central Point, Oregon, is a proven grower of full-spectrum hemp biomass grown using premium seed genetics that contain less than 0.3% THC and exceptionally high cannabinoid (CBD) content of up to 20%. The company's "soil to oil" methodology combines seasoned professionals working in hand-picked agricultural microclimates located in Oregon's famed Emerald Triangle, Kentucky and Colorado.

Hemptown has exclusive rights to 1 million rare CBG (cannabigerol) seeds genetically programmed to yield from 15% to 20% full-spectrum non-intoxicating cannabinoids. As a result of a long-standing relationship with the one of the world's most respected cannabis breeding companies – Oregon CBD Seeds – Hemptown is positioned to be a leading CBG producer in the U.S. in 2019 and beyond.

In 2018 Hemptown's harvest from its Oregon hemp farm was 150,000 pounds of full-spectrum biomass with CBD content hovering around 17%. 2018 harvest revenue expected to range from $8.1 million to $12.6 million. The company is scaling up operations in 2019 to meet market demands and projects it will reap over 1,000,000 pounds. By 2020, Hemptown projects potential revenues in the $100 million to $200 million range are possible once additional farming operations are at full strength.

Growth Strategy

By 2020, Hemptown anticipates it will have more than 3,000 acres in several states dedicated to hemp farming. Expansion plans include increasing in-house extraction capabilities to boost profit margins by providing additional CBD and CBG isolates and distillation services. Development of business-to-business channels as well as new products and formulations for the direct-to-consumer market, along with several strategic acquisitions, are also key to Hemptown's growth strategy.

Hemptown plans to expand distribution and growing operations globally through strategic partnerships and development of contracts with leading Fortune 500 brands in European markets. The company intends to grow its IP portfolio by developing a proprietary water-soluble cannabinoid delivery system. Not to be confused with water-compatibility, water-soluble cannabinoids combine seamlessly with other liquids, have a superior shelf life, and deliver dramatically increased efficacy to the consumer.

Branded Products

Hemptown's first in-house branded product line combines the inspiring strength found in the unbridled nature that surrounds the company's original hemp farm in the Siskiyou Klamath region of Oregon. Sisku is set to redefine the cannabinoid packaged goods space with an elegant look, clean feel and potent, reliable efficacy.

Custom product lines can also be created for any product manufacturer as Hemptown brings GMP and ISO accredited processing facilities online in 2019. Together with Oregon CBD Seeds and Hemptown's product sciences team, Hemptown will be able to create custom, proprietary full-spectrum CBD and CBG oils and pure isolates.

Management Team

Company Chairman Rod Wolterman founded Hemptown's Oregon operations in 2016. He has extensive experience in the cannabis sector having been active within the space since 1998. Wolterman has also acted as a private equity investor in numerous medical marijuana dispensaries and cultivation operations in southern California.

CEO John Cummings has over 20 years of experience in finance, marketing, sales and project management. He led the compliance and special projects efforts for Kings Garden, one of the largest vertically integrated operators in California. Cummings also spent a year in Europe launching the continent's first GMP and ISO-accredited cultivation and manufacturing facility.

Dr. Gordon Chiu is chief science officer for Hemptown USA. He has more than 15 years of combined domestic and international experience in biomedical, chemical, cosmetic, medical and technology industries. A graduate of Rensselaer Polytechnic Institute with a master's degree from Seton Hall University, Chiu is leading Hemptown's cannabinoid research team and is responsible for filing IP patents, specifically in the areas of water-solubility, bioavailability and peptide sequencing.


Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted in a publication from Financialnewsmedia.com, examining how the cannabis marketplace is growing in every way every day. More dispensaries, more acres under cultivation, more products being ‘infused’, more mergers and acquisitions… and more and more news. Also today, the company was featured in the 420 with CNW by CannabisNewsWire.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $2.44, up 2.47%, on 158,072 volume with 286 trades. The average volume for the last 3 months is 261,106 and the stock's 52-week low/high is $1.8068/$5.20.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) has now launched its FirstNet Ready Uniden UV350 4G/LTE In-Vehicle Device for Public Safety (http://nnw.fm/vhW8m), representing a milestone in the company’s development. Siyata’s UV350 is the first in-vehicle mounted phablet that’s been tested and approved for use on both the AT&T and FirstNet networks.

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed the day's trading session at $0.3606, up 0.39%, on 2,100 volume with 3 trades. The average volume for the last 3 months is 64,866 and the stock's 52-week low/high is $0.254/$0.4462.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Vancouver-based cannabis brand Choom™ (CSE: CHOO; OTCQB: CHOOF) unveils its retail concept and experience tomorrow in Niagara Falls, Ontario. As one of 25 cannabis stores authorized to open in the province, Choom Niagara provides a curated selection of premium products in an immersive environment designed to elevate and empower consumers. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how the cannabis marketplace is growing in every way every day. More dispensaries, more acres under cultivation, more products being ‘infused’, more mergers and acquisitions… and more and more news.

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.36, up 1.41%, on 174,319 volume with 134 trades. The average volume for the last 3 months is 423,027 and the stock's 52-week low/high is $0.285/$1.129.

Recent News

chart

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) announces the availability of an audio press release titled, “Swelling Battery Demand Keeps Indonesian Nickel Sector Strong.” To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/keQx6. To read the full editorial, visit: http://nnw.fm/gO4b4.

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed the day's trading session at $0.1101, up 5.87%, on 29,498 volume with 11 trades. The average volume for the last 3 months is 23,738 and the stock's 52-week low/high is $0.0701/$0.337.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG) has named Elepreneur President Keith Halls and Elepreneur CEO Kip Allison as members of the SHRG board. Additionally, SHRG plans to add four independent members to its board as it pursues an uplisting to the Nasdaq, according to SHRG CEO John “JT” Thatch.

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed the day's trading session at $0.18, even for the day, on 23,443 volume with 1 trade. The average volume for the last 3 months is 23,443 and the stock's 52-week low/high is $0.142/$0.3944.

Recent News

chart

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) was highlighted today in a publication from FN Media Group, examining how much has changed in the aftermath of the World Health Organization’s (WHO) marijuana reclassification recommendation back in February — in particular, the potential for the European Union (EU) CBD market.

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed the day's trading session at $6.27, off by 7.79%, on 1,540,433 volume with 5,634 trades. The average volume for the last 3 months is 1,047,152 and the stock's 52-week low/high is $2.97/$8.44.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (OTCQB: GRYN) (“GRYN" or the “Company"), an innovative, science-driven premium cannabis cultivation and branding enterprise, announces it has secured from the County of San Diego Department of Agriculture, Weights and Measures a registration for industrial hemp cultivation as a grower. The California Industrial Hemp Farming Act authorizes the commercial production of industrial hemp in California. As a registered grower in the county of San Diego, Green Hygienics lengthens its stride in the California cannabis market and expands the Company’s cultivation capabilities to multiple states (http://nnw.fm/H0ugq). Also today, the company was featured in the 420 with CNW by CannabisNewsWire. From the first day of 2020, no employer in Nevada will be allowed to deny a job applicant employment just because that individual tested positive for marijuana during a pre-employment drugs test. The ban is contained in a bill which was signed into law by Gov. Sisolak on June 5. This makes Nevada the first state to enact such legislation in the country.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $1.41, off by 21.67%, on 63,558 volume with 74 trades. The average volume for the last 3 months is 21,317 and the stock's 52-week low/high is $0.10/$1.81.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Vancouver-based company Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) was recently mentioned in the article 'Saks Fifth Avenue Is Now Serving CBD Beauty At New York City Flagship's In-House Salon' authored by Katie Chapiro on Forbes.com. Among other top brands such as CocoCanna, Ambika Herbal and Highborn, Wildflower stands out for its dedication to keeping its products all-natural and synergic. Using more than just CBD oil, Wildflower combines unique ingredients including ginseng and curcumin to form its distinctive wellness products. To view the full article, visit: http://nnw.fm/W8sr3.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.4528, off by 1.43%, on 1,750 volume with 4 trades. The average volume for the last 3 months is 23,648 and the stock's 52-week low/high is $0.009/$1.129.

Recent News

chart

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)

The QualityStocks Daily Newsletter would like to spotlight Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF).

Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), announces that Non-executive Chairman of the board, Justin Chorbajian has tendered his resignation. Company president Karl Kottmeier commented, "On behalf of the board I'd like to thank Justin for his contributions to the Company over the past twenty-two months, and we wish him well in his future endeavors."

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.

Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.

  • Investment and funding for rapid growth
  • Vertical integration solutions
  • Construction, design and/or optimization of indoor or outdoor cultivation facilities
  • Reputation management & influencer outreach
  • Branding and Packaging
  • Social Media and Media outreach

With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.

Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.

Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.

Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."

Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.

Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).

Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.

Chemistree Technology Inc. (CHMJF), closed the day's trading session at $0.2708, up 11.21%, on 49,821 volume with 36 trades. The average volume for the last 3 months is 107,412 and the stock's 52-week low/high is $0.268/$0.605.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands LP (OTC: VPRB) holds U.S. and Chinese patents for atomization-related products. VPR Brands’ broad portfolio of tested vaporizer products is driving sales and supporting strong year-over-year financial growth. Also today, NetworkNewsWire released a report on the company further detailing how VPRB boasts a strong portfolio of diverse brands targeting several cannabis and CBD-oil industry sectors

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed the day's trading session at $0.053, off by 1.85%, on 500 volume with 1 trade. The average volume for the last 3 months is 76,182 and the stock's 52-week low/high is $0.026/$0.1397.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (MCOA) was highlighted in a publication from Financialnewsmedia.com, examining how much has changed in the aftermath of the World Health Organization’s (WHO) marijuana reclassification recommendation back in February — in particular, the potential for the European Union (EU) CBD market.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0117, off by 0.85%, on 5,397,599 volume with 178 trades. The average volume for the last 3 months is 10,611,396 and the stock's 52-week low/high is $0.01025/$0.0489.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint’s (OTCQB: SING) emphasis is on acquiring companies that will immediately benefit from the injection of technology integration and growth capital. Headquartered in Phoenix, Arizona, SinglePoint looks for undervalued, cash-flow positive companies that have high potential and verified assets (http://nnw.fm/9YZ9f). Also today, NetworkNewsWire released a report on the company detailing how SING is paving the way for qualified cannabidiol (“CBD”) product companies to bring their products to the national market. To view the full article, visit: http://nnw.fm/TN9Tc.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0113, off by 1.31%, on 1,108,701 volume with 67 trades. The average volume for the last 3 months is 3,917,570 and the stock's 52-week low/high is $0.009/$0.0675.

Recent News

chart

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed the day's trading session at $0.5501, even for the day, on 8 volume with 1 trade. The average volume for the last 3 months is 3,507 and the stock's 52-week low/high is $0.23/$0.89.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.